{"entity":{"type":"insider","cik":"0001887435","url":"/insider/0001887435","json_url":"/insider/0001887435.json","name":"TomEnterprise AB","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2022-07-21","last":"2025-07-25","span_basis":"filed_date"},"name_variants":[{"name":"TomEnterprise AB","source":"filing","n_filings":5,"first_seen":"2022-07-21","last_seen":"2025-07-25"}],"transactions":[{"id":4168319,"accession":"0001104659-25-070900","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-070900","line_url":"/filing/0001104659-25-070900#line-1","is_derivative":false,"issuer_cik":"0001401040","issuer_name":"DiaMedica Therapeutics Inc.","issuer_ticker":"DMAC","issuer_name_source":null,"issuer_url":"/issuer/0001401040","owner_cik":null,"owner_name":"TomEnterprise Private AB; TomEnterprise AB; Von Koch Thomas","owner_display_name":"TomEnterprise Private AB","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2857142.0,"shares_display":"2,857,142","price_per_share":3.5,"price_display":"3.50","price_state":"stated","total_value":9999997.0,"total_display":"9,999,997.00","total_whole":"9,999,997","shares_owned_after":8383577.0,"shares_owned_after_display":"8,383,577","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-07-23","filed_date":"2025-07-25","scope":"insider"},{"id":3067382,"accession":"0001104659-24-076844","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-076844","line_url":"/filing/0001104659-24-076844#line-1","is_derivative":false,"issuer_cik":"0001401040","issuer_name":"DiaMedica Therapeutics Inc.","issuer_ticker":"DMAC","issuer_name_source":null,"issuer_url":"/issuer/0001401040","owner_cik":null,"owner_name":"Von Koch Thomas; TomEnterprise Private AB; TomEnterprise AB","owner_display_name":"Von Koch Thomas","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200000.0,"shares_display":"1,200,000","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":5526435.0,"shares_owned_after_display":"5,526,435","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-06-28","filed_date":"2024-07-01","scope":"insider"},{"id":8429870,"accession":"0001104659-23-075250","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-075250","line_url":"/filing/0001104659-23-075250#line-1","is_derivative":false,"issuer_cik":"0001401040","issuer_name":"DiaMedica Therapeutics Inc.","issuer_ticker":"DMAC","issuer_name_source":null,"issuer_url":"/issuer/0001401040","owner_cik":null,"owner_name":"Von Koch Thomas; TomEqt Private AB; TomEnterprise AB","owner_display_name":"Von Koch Thomas","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1470588.0,"shares_display":"1,470,588","price_per_share":3.4,"price_display":"3.40","price_state":"stated","total_value":4999999.2,"total_display":"4,999,999.20","total_whole":"4,999,999","shares_owned_after":4326435.0,"shares_owned_after_display":"4,326,435","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-06-23","filed_date":"2023-06-27","scope":"insider"},{"id":6687254,"accession":"0001567619-22-021344","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-021344","line_url":"/filing/0001567619-22-021344#line-2","is_derivative":false,"issuer_cik":"0001401040","issuer_name":"DiaMedica Therapeutics Inc.","issuer_ticker":"DMAC","issuer_name_source":null,"issuer_url":"/issuer/0001401040","owner_cik":null,"owner_name":"TomEqt Private AB; TomEnterprise AB; Von Koch Thomas","owner_display_name":"TomEqt Private AB","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2855847.0,"shares_display":"2,855,847","price_per_share":1.235,"price_display":"1.24","price_state":"stated","total_value":3526971.045,"total_display":"3,526,971.04","total_whole":"3,526,971","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-06","scope":"insider"},{"id":6687252,"accession":"0001567619-22-021344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-021344","line_url":"/filing/0001567619-22-021344#line-1","is_derivative":false,"issuer_cik":"0001401040","issuer_name":"DiaMedica Therapeutics Inc.","issuer_ticker":"DMAC","issuer_name_source":null,"issuer_url":"/issuer/0001401040","owner_cik":null,"owner_name":"TomEqt Private AB; TomEnterprise AB; Von Koch Thomas","owner_display_name":"TomEqt Private AB","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2855847.0,"shares_display":"2,855,847","price_per_share":1.235,"price_display":"1.24","price_state":"stated","total_value":3526971.045,"total_display":"3,526,971.04","total_whole":"3,526,971","shares_owned_after":2855847.0,"shares_owned_after_display":"2,855,847","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-02","filed_date":"2022-12-06","scope":"insider"},{"id":6687060,"accession":"0001567619-22-014290","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-014290","line_url":"/filing/0001567619-22-014290#line-1","is_derivative":false,"issuer_cik":"0001401040","issuer_name":"DiaMedica Therapeutics Inc.","issuer_ticker":"DMAC","issuer_name_source":null,"issuer_url":"/issuer/0001401040","owner_cik":null,"owner_name":"TomEnterprise AB; Von Koch Thomas","owner_display_name":"TomEnterprise AB","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":2,"other_reporting_owners":1,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":207974.0,"shares_display":"207,974","price_per_share":1.3266,"price_display":"1.33","price_state":"stated","total_value":275898.3084,"total_display":"275,898.31","total_whole":"275,898","shares_owned_after":2855827.0,"shares_owned_after_display":"2,855,827","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-07-08","filed_date":"2022-07-21","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001401040","name":"DiaMedica Therapeutics Inc.","url":"/issuer/0001401040","role":"Ten percent owner","n_filings":5,"first_seen":"2022-07-21","last_seen":"2025-07-25"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001887435","retrieved_at":"2026-08-22T12:47:19+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}